510(k) K163085

Device
Simplexa C. Difficile Direct; Simplexa C. Difficile Positive Control Pack
Applicant
Focus Diagnostics, Inc.: DBA DiaSorin Molecular LLC
510(k) number
K163085
Product code
OZN  
Decision
Substantially Equivalent (SESE)
Decision date
2017-02-14
Date received
2016-11-03
Regulation
866.3130
Classification name
C. Difficile Toxin Gene Amplification Assay
Medical specialty
Microbiology
Review panel
Microbiology
Device class
2
Clearance type
Traditional
Statement or summary
Summary
Third party reviewed
No

Applicant Contact#

Contact
Irene M. Guzman
Address
11331 Valley View St. Cypress CA US 90630 90630

FDA Registration Numbers#

Source Documents#

510(k) summary PDF

Other 510(k) Records For Product Code OZN  #

510(k), Device, Applicant table
510(k)DeviceApplicantDecision date
K243730Xpert C. difficile/EpiCepheid®2025-02-28
K232092Great Basin Toxigenic C. difficile Direct Test (CDF2)Vela Operations USA2023-11-14
K212427cobas Cdiff nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2021-10-20
K210385cobas Cdiff nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2021-09-09
K172569GenePOC CDiffGenepoc, Inc.2017-11-22
K171770cobas Cdiff Nucleic acid test for use on the cobas Liat SystemRoche Molecular Systems, Inc.2017-09-12
K171441ARIES C. difficile Assay Complete Kit, ARIES C. difficile Assay Protocol File Kit, ARIES C. difficile Assay Kit (24 cassettes), ARIES Stool Resuspension KitLuminex Corporation2017-07-21
K170491Solana C. difficile AssayQuidel Corporation2017-05-11
K142422cobas Cdiff TestRoche Molecular Systems, Inc.2015-05-20
K133936ARTUS C. DIFFICILE QS-RGQ MDX KITQIAGEN GmbH2014-04-04
K132726ICEPLEX C. DIFFICILE ASSAY KIT, ICEPLEX SYSTEMPrimeradx2013-11-29
K132235IMDX C.DIFFICILE FOR ABBOTT M2000Intelligent Medical Devices, Inc.2013-10-11
K130470BD MAX CDIFF ASSAY, BD MAX INSTRUMENTGeneohm Sciences Canada, Inc. (Bd Diagnostics)2013-04-02
K123998QUIDEL MOLECULAR DIRECT C. DIFFICILE ASSAYQuidel Corp.2013-03-08
K123355AMPLIVUE C. DIFFICILE ASSAYQuidel Corporation2012-12-13

Legacy Summary#

summary

FDA Review#

Decision Summary